+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

Targeted Therapy Market Report 2025 - Product Thumbnail Image

Targeted Therapy Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Solid Tumor Cancer Treatment Market Report 2025 - Product Thumbnail Image

Solid Tumor Cancer Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
Anti-CD20 Antibody - Pipeline Insight, 2025 - Product Thumbnail Image

Anti-CD20 Antibody - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Bio/Pharmaceutical Outsourcing Report, May 2025 - Product Thumbnail Image

Bio/Pharmaceutical Outsourcing Report, May 2025

  • Report
  • May 2025
  • 24 Pages
  • Global
From
Histoplasmosis Treatment Market Report 2025 - Product Thumbnail Image

Histoplasmosis Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Amyloid Beta-protein Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Amyloid Beta-protein Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028 - Product Thumbnail Image

Pharmaceutical Spray Drying Market (2nd Edition), 2018-2028

  • Report
  • April 2018
  • 200 Pages
  • Global
From
Loading Indicator